Discordant neutralizing antibody and T cell responses in asymptomatic and mild SARS-CoV-2 infection

Catherine J. Reynolds(Imperial College London), Leo Swadling(University College London), Joseph M. Gibbons(Queen Mary University of London), Corinna Pade(Queen Mary University of London), Melanie P. Jensen(St Bartholomew's Hospital), Mariana O. Diniz(University College London), Nathalie Schmidt(University College London), David K. Butler(Imperial College London), Oliver E. Amin(University College London), Sasha N. L. Bailey(Imperial College London), Sam M. Murray(Imperial College London), Franziska P. Pieper(Imperial College London), Stephen Taylor(Public Health England), Jessica Jones(Public Health England), Meleri Jones(Queen Mary University of London), Wing-Yiu Jason Lee(Queen Mary University of London), Joshua Rosenheim(University College London), Aneesh Chandran(University College London), George Joy(St Bartholomew's Hospital), Cecilia Di Genova(Medway School of Pharmacy), Nigel Temperton(Medway School of Pharmacy), Jonathan Lambourne(Barts Health NHS Trust), Teresa Cutiño‐Moguel(Barts Health NHS Trust), Mervyn Andiapen(St Bartholomew's Hospital), Marianna Fontana(Royal Free London NHS Foundation Trust), Angelique Smit(Royal Free London NHS Foundation Trust), Amanda Semper(Public Health England), Benjamin O’Brien(St Bartholomew's Hospital), Benny Chain(University College London), Tim Brooks(Public Health England), Charlotte Manisty(St Bartholomew's Hospital), Thomas A. Treibel(St Bartholomew's Hospital), James Moon(St Bartholomew's Hospital), COVIDsortium investigators(University College London), Mahdad Noursadeghi(University College London), COVIDsortium immune correlates network(University College London), Daniel M. Altmann(Queen Mary University of London), Mala K. Maini(Royal Brompton & Harefield NHS Foundation Trust), Áine McKnight(Queen Mary University of London), Rosemary J. Boyton(Royal Brompton & Harefield NHS Foundation Trust)
Science Immunology
December 18, 2020
Cited by 217Open Access
Full Text

Abstract

Understanding the nature of immunity following mild/asymptomatic infection with SARS-CoV-2 is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody responses in 136 healthcare workers (HCW) 16-18 weeks after United Kingdom lockdown, 76 of whom had mild/asymptomatic SARS-CoV-2 infection captured by serial sampling. Neutralizing antibodies (nAb) were present in 89% of previously infected HCW. T cell responses tended to be lower following asymptomatic infection than in those reporting case-definition symptoms of COVID-19, while nAb titers were maintained irrespective of symptoms. T cell and antibody responses were sometimes discordant. Eleven percent lacked nAb and had undetectable T cell responses to spike protein but had T cells reactive with other SARS-CoV-2 antigens. Our findings suggest that the majority of individuals with mild or asymptomatic SARS-CoV-2 infection carry nAb complemented by multispecific T cell responses at 16-18 weeks after mild or asymptomatic SARS-CoV-2 infection.


Related Papers

No related papers found

Powered by citation graph analysis